Cart
- Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity.
- This cost encompasses both the medication for 4 weeks and your consultation.
- It undergoes thorough sterile assessments to ensure quality and uniformity.
- It is combined with Vitamin B12 to mitigate potential nausea symptoms.